Based on our present data and previous reports, ZA inhibited the interaction between Tregs and breast cancer cells and synergistically acted with cyotokine or IDO inhibitors to alert the tumor microenvironment and to enhanced anti-tumor immunity. Here, IDO1 is linked to breast carcinoma.